Full record

Hittech

Nano Dimension (NNDM) will not achieve positive EBITDA before 2024

A scored prediction by Tom Nash, made on .

VideoQuote from the original sourcetechmarkets

Scored prediction

Hittech

I'm not expecting any positive EBITDA until 2024

Nano Dimension (NNDM) will not achieve positive EBITDA before 2024

Made on
2020-12-24
Outcome
Hit
Importance
2 / 5
Effect on score
+1.84

What counted as right

Status
resolved
Settled on
2023-12-31

NNDM does not report positive EBITDA in any reported period before 2024-01-01

Criterion: NNDM does not report positive EBITDA in any period before 2024-01-01. Confirmed negative EBITDA across FY2021, FY2022, and FY2023 — prediction's condition holds. Resolved; outcome value assigned later.

Sources

  • we need to talk... [about NNDM]

    YouTube ·

    Source

Evidence of what happened

  • Nano Dimension's FY2023 results report EBITDA (loss) of -$94.958M and Adjusted EBITDA (loss) of -$99.942M, with a net loss of $55.66M — EBITDA was negative for full-year 2023, the last reporting period before 2024-01-01.

    Evidence

  • Prior years were also deeply EBITDA-negative: FY2022 loss before taxes ~$228M with negative EBITDA/adjusted EBITDA, and FY2021 loss before taxes ~$206M with negative EBITDA (~-$200M) — NNDM reported no positive EBITDA in any period from IPO through 2023.

    Evidence

Corrections

No public corrections.

Effect on the score

+1.84
How sure they sounded
80%
Outcome
Hit
Importance
2 / 5

This page shows the scored prediction as published; the site doesn't recompute or adjust the score.

Where this came from

Nano Dimension (NNDM) will not achieve positive EBITDA befo…
Methodology version
v1.0.0
Last computed
August 2, 2026
Made on
2020-12-24

How this profile was built

  1. Scored by independent judges

  2. Predictions gathered and sourced

  3. Independently verified against sources

Every public score traces back to sourced prediction records.

Avow is an independent project. The pundits scored here are not affiliated with Avow and do not endorse it. Names and likenesses are used for identification and commentary.

Evidence firstMethodologyPrivacy